Allena Pharmaceuticals, Inc.
ALNAQ · OTC
6/30/2022 | 3/31/2022 | 12/31/2021 | 9/30/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $7 | $9 | $30 | $40 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $10 | $11 | $3 | $2 |
| Total Curr. Assets | $16 | $20 | $33 | $42 |
| Property Plant & Equip (Net) | $1 | $1 | $2 | $2 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $1 | $2 | $2 | $2 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $18 | $22 | $35 | $44 |
| Liabilities | – | – | – | – |
| Payables | $2 | $3 | $1 | $3 |
| Short-Term Debt | $0 | $5 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $8 | $2 | $14 | $4 |
| Total Curr. Liab. | $10 | $10 | $16 | $8 |
| LT Debt | $0 | $0 | $0 | $10 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $3 | $0 | $0 | $0 |
| Total NC Liab. | $4 | $8 | $0 | $10 |
| Other Liabilities | $0 | -$8 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $14 | $10 | $16 | $18 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$267 | -$258 | -$246 | -$236 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $270 | $270 | $265 | $262 |
| Total Equity | $4 | $12 | $19 | $26 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $18 | $22 | $35 | $44 |
| Net Debt | -$6 | -$4 | -$29 | -$30 |